Drug Shortage Report for MYLAN-VENLAFAXINE XR

Last updated on 2018-07-04 History
Report ID 5909
Drug Identification Number 02310295
Brand name MYLAN-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-06-26
Estimated end date Unknown
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-04
Company comments discontinued in ID 20306
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2018-07-04 English Compare
v25 2018-07-03 French Compare
v24 2018-07-03 English Compare
v23 2018-06-29 French Compare
v22 2018-06-29 English Compare
v21 2018-06-25 French Compare
v20 2018-06-25 English Compare
v19 2018-06-23 English Compare
v18 2018-05-11 French Compare
v17 2018-05-11 English Compare
v16 2018-04-30 French Compare
v15 2018-04-30 English Compare
v14 2018-04-24 English Compare
v13 2018-03-02 French Compare
v12 2018-03-02 English Compare
v11 2018-03-02 English Compare
v10 2017-10-23 French Compare
v9 2017-10-23 English Compare
v8 2017-10-23 English Compare
v7 2017-05-05 French Compare

Showing 1 to 20 of 26